Publications
207
Citations
14,277
Est. group size
—
Recurring co-author estimate
Active years
34
Publishing since 1993
Kenneth E. White studies how the body regulates minerals such as phosphate and vitamin D, focusing on a hormone called Fibroblast Growth Factor 23 (FGF23) and how bones and kidneys communicate to control it. Much of the work examines what goes wrong in chronic kidney disease and related mineral and bone disorders, using genetic and single-cell molecular techniques to trace the underlying pathways. The research also connects these mineral-regulating systems to conditions such as anemia and heart problems in kidney disease.
Publication activity has been steady over the past decade, averaging about six papers per year, with a notable uptick in 2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- The genetics and outcomes of an altered FGF23-1,25D-PTH axis in diseases of mineral metabolism
Journal of Bone and Mineral Research · 2026
- Integrative genetic and transcriptomic analyses reveal alternative carcinogenetic pathways in basal cell carcinoma
Genes & Diseases · 2026
- A proposed path to explaining the unexplained anemia of aging
The Journals of Gerontology Series A · 2025
- ETV1 Is a Proximal Tubule-Specific Transcription Factor Controlling Converse Fibroblast Growth Factor 23 (FGF-23) and PTH Regulation of Vitamin D Synthesis
Journal of the American Society of Nephrology · 2025
- Fibroblast Activation Protein (FAP) Modulates Fibrotic Changes and Potential Stromal-Epithelial Cell Interactions in CKD
Journal of the American Society of Nephrology · 2025
- ETV1 Transcription Factor Mediates Fibroblast Growth Factor 23 (FGF-23) Genomic Control of Vitamin D Metabolism and PTH Suppression
Journal of the American Society of Nephrology · 2025
- Systemic Phosphate Elevations Induce Fibroblast Growth Factor 23 Production in Skeletal Muscle to Reduce Renal Phosphate Reabsorption in Mice
Journal of the American Society of Nephrology · 2025
- Fibroblast Growth Factor 23 Bioactivity Induces General and Cell Type-Specific Kidney Genomic Reprogramming as Detected by Single-Cell Multiomics
Journal of the American Society of Nephrology · 2024
- Common Sense and Uncommon Sense
Journal of Scottish Thought · 2024
- Regulation of FGF23 production and phosphate metabolism by bone–kidney interactions
Nature Reviews Nephrology · 2023
- Merged In Vitro/In Vivo RNAseq/ATACseq Pinpointed FGF23 Target Genes Dysregulated with Klotho Deletion in Kidney Single-Cell Subpopulations
Journal of the American Society of Nephrology · 2023
- Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease
Kidney International · 2022
- Anemia and fibroblast growth factor 23 elevation in chronic kidney disease: homeostatic interactions and emerging therapeutics
Current Opinion in Nephrology & Hypertension · 2022
- FGF23 Drives Transcriptional and Genomic Accessibility Reprogram-ming as Identified in the KL-KO Mouse at the Single Cell Level
Journal of the American Society of Nephrology · 2022
- Dissecting Ferric Citrate- and FGF-23-Associated Mineral Metabolism During the Anemia of CKD
Journal of the American Society of Nephrology · 2020
- Journal of the American Society of Nephrology×14
- PMC×10
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Journal of Bone and Mineral Research×4
- Kidney International×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile